Literature DB >> 20020263

Role of reactive metabolites in drug-induced hepatotoxicity.

A Srivastava1, J L Maggs, D J Antoine, D P Williams, D A Smith, B K Park.   

Abstract

Drugs are generally converted to biologically inactive forms and eliminated from the body, principally by hepatic metabolism. However, certain drugs undergo biotransformation to metabolites that can interfere with cellular functions through their intrinsic chemical reactivity towards glutathione, leading to thiol depletion, and functionally critical macromolecules, resulting in reversible modification, irreversible adduct formation, and irreversible loss of activity. There is now a great deal of evidence which shows that reactive metabolites are formed from drugs known to cause hepatotoxicity, such as acetaminophen, tamoxifen, isoniazid, and amodiaquine. The main theme of this article is to review the evidence for chemically reactive metabolites being initiating factors for the multiple downstream biological events culminating in toxicity. The major objectives are to understand those idiosyncratic hepatotoxicities thought to be caused by chemically reactive metabolites and to define the role of toxic metabolites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20020263     DOI: 10.1007/978-3-642-00663-0_7

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  33 in total

Review 1.  Molecular mechanisms underlying chemical liver injury.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Expert Rev Mol Med       Date:  2012-02-03       Impact factor: 5.600

2.  In vivo assessment of intracellular redox state in rat liver using hyperpolarized [1-13 C]Alanine.

Authors:  Jae Mo Park; Chalermchai Khemtong; Shie-Chau Liu; Ralph E Hurd; Daniel M Spielman
Journal:  Magn Reson Med       Date:  2017-03-05       Impact factor: 4.668

3.  TRPM2 channels mediate acetaminophen-induced liver damage.

Authors:  Ehsan Kheradpezhouh; Linlin Ma; Arthur Morphett; Greg J Barritt; Grigori Y Rychkov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

4.  M1 muscarinic receptors modify oxidative stress response to acetaminophen-induced acute liver injury.

Authors:  Nathalie H Urrunaga; Ravirajsinh N Jadeja; Vikrant Rachakonda; Daniel Ahmad; Leon P McLean; Kunrong Cheng; Vijay Shah; William S Twaddell; Jean-Pierre Raufman; Sandeep Khurana
Journal:  Free Radic Biol Med       Date:  2014-10-31       Impact factor: 7.376

5.  Evaluation of DILI Predictive Hypotheses in Early Drug Development.

Authors:  Rosa Chan; Leslie Z Benet
Journal:  Chem Res Toxicol       Date:  2017-03-15       Impact factor: 3.739

6.  Metabolic Activation of Elemicin Leads to the Inhibition of Stearoyl-CoA Desaturase 1.

Authors:  Xiao-Nan Yang; Yi-Kun Wang; Xu Zhu; Xue-Rong Xiao; Man-Yun Dai; Ting Zhang; Yan Qu; Xiu-Wei Yang; Hong-Bo Qin; Frank J Gonzalez; Fei Li
Journal:  Chem Res Toxicol       Date:  2019-09-10       Impact factor: 3.739

7.  Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.

Authors:  Jiekun Xuan; Si Chen; Baitang Ning; William H Tolleson; Lei Guo
Journal:  Chem Biol Interact       Date:  2015-10-22       Impact factor: 5.192

Review 8.  An overview on the proposed mechanisms of antithyroid drugs-induced liver injury.

Authors:  Reza Heidari; Hossein Niknahad; Akram Jamshidzadeh; Mohammad Ali Eghbal; Narges Abdoli
Journal:  Adv Pharm Bull       Date:  2015-03-05

9.  Relationship between structural alerts in NSAIDs and idiosyncratic hepatotoxicity: an analysis of spontaneous report data from the WHO database.

Authors:  Naomi Jessurun; Eugene van Puijenbroek
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.606

10.  Lycium barbarum extract provides effective protection against paracetamol-induced acute hepatotoxicity in rats.

Authors:  Ercan Gündüz; Recep Dursun; Yılmaz Zengin; Mustafa İçer; Hasan Mansur Durgun; Ayşe Kanıcı; İbrahim Kaplan; Ulaş Alabalık; Hüseyin Gürbüz; Cahfer Güloğlu
Journal:  Int J Clin Exp Med       Date:  2015-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.